Cargando…
Process Development for the Care of the Person Under Investigation for Ebola Virus Disease: a Collaboration of Biocontainment Unit and Emergency Medicine Personnel
Patients presenting with epidemiological risk factors for Ebola virus disease (EVD) and symptoms consistent with the disease require screening with a molecular assay. If the initial test is negative, but the patient has been symptomatic for less than 3 days, a follow-up test is required to reliably...
Autores principales: | Schwedhelm, Shelly S., Wadman, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100528/ https://www.ncbi.nlm.nih.gov/pubmed/32226327 http://dx.doi.org/10.1007/s40506-016-0099-z |
Ejemplares similares
-
A Brief History of Biocontainment
por: Cieslak, Theodore J, et al.
Publicado: (2016) -
Ebola and the eye
por: Clare, Gerry
Publicado: (2020) -
Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization
por: Bodmer, Bianca S., et al.
Publicado: (2023) -
N(6)-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses
por: Wendt, Lisa, et al.
Publicado: (2023) -
Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses
por: Pinski, Amanda N., et al.
Publicado: (2021)